# Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

> **NCT01197378** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 60 (actual)

## Conditions studied

- Cystinosis

## Interventions

- **DRUG:** Cysteamine Bitartrate Delayed-release Capsules

## Key facts

- **NCT ID:** NCT01197378
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-27
- **Primary completion:** 2017-06-26
- **Final completion:** 2017-06-26
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01197378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01197378, "Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01197378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*